Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study
Year: 2023
Type: article
Source: Radiotherapy and Oncology
Authors: Mark T. Corkum, Mark K. Buyyounouski, Albert J. Chang, Hans T. Chung, Peter Chung, Brett W. Cox, Juanita M. Crook, Brian J. Davis, Steven J. Frank, Ivan Henriquez, Eric M. Horwitz, Peter Hoskin, I-Chow Hsu, Mira Keyes, Martin T. King, Marisa A. Kollmeier, Daniel J. Krauss, Andrzej M. Kukielka, Gerard Morton, Peter F. Orio, Bradley R. Pieters, Louis Potters, Peter J. Rossi, Timothy N. Showalter, Abhishek A. Solanki, Daniel Song, Ben Vanneste, Eric Vigneault, Piotr A. Wojcieszek, Michael J. Zelefsky, Mitchell Kamrava
Institutions: University of Ottawa, Ottawa Hospital, Stanford Medicine, Stanford University, University of California, Los Angeles, Sunnybrook Health Science Centre, University of Toronto, Odette Cancer Centre, University Health Network, Princess Margaret Cancer Centre, University of British Columbia, Mayo Clinic, The University of Texas MD Anderson Cancer Center, Hospital Universitari Sant Joan de Reus, Fox Chase Cancer Center, University of Manchester, Mount Vernon Cancer Centre, University of California, San Francisco, BC Cancer Agency, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Memorial Sloan Kettering Cancer Center, Beaumont Health, Szpital Uniwersytecki w Krakowie, Amsterdam University Medical Centers, Cancer Center Amsterdam, University of Amsterdam, Northwell Health, Emory University, Winship Cancer Institute, University of Virginia, Loyola University Chicago, Johns Hopkins University, Johns Hopkins Medicine, Maastricht University Medical Centre, Maastricht University, Hôpital de l'Enfant-Jésus, The Maria Sklodowska-Curie National Research Institute of Oncology, Cedars-Sinai Medical Center
Language: English
Subfield: Urology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4365448120
